Picture of Health Catalyst logo

HCAT — Health Catalyst News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapNeutral

Health Catalyst Inc reports results for the quarter ended in September - Earnings Summary

* Health Catalyst Inc  HCAT.OQ  reported a quarterly
adjusted loss
of 13 cents​​ per share for the quarter ended in September. The
mean expectation of fourteen analysts for the quarter was for a
loss of 19 cents per share.
    * Revenue rose 10.7% to $68.35 million from a year ago;
analysts
expected $66.79 million. 
    * Health Catalyst Inc's reported EPS for the quarter was a
loss
of 84 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Health Catalyst Inc shares had fallen by 29.2% this
quarter and
lost 82.7% so far this year.
    * The company reported a quarterly loss of $45.74 million.
    * Wall Street's median 12-month price target for Health
Catalyst
Inc is $17.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 10:52 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.19          -0.13          Beat
 Jun. 30 2022      -0.10          -0.03          Beat
 Mar. 31 2022      -0.11          -0.06          Beat
 Dec. 31 2021      -0.21          -0.19          Beat

Recent news on Health Catalyst

See all news